8 April 2002, Chemical World

Arvind Remedies to build manufacturing unit in Tamilnadu


Arvind Remedies Ltd is setting up a world-class facility near Chennai to take up manufacturing of tablets, injectables and soft gelatin capsules. The facility, which will be operational by 2003, will confirm to the US FDA standard and UK MCA standards and will involve an investment of Rs.50 Crores.

The company also intends to re-focus the therapeutic segments. It will be present in and is looking at endocrinology, dermatology, cardiovascular diseases and nutrition as the new focus areas and intends to launch newer products over the next year. These segments would contribute to 30 percent of its turnover in future.

The company is already present in pediatrics, pain management, gynaecology and diabetes segment, which together contribute around 60 percent of the companies total turnover.

Currently, allopathic medicines contribute around 70 percent of the total revenues of Arvind Remedies, and the balance comes from ayurvedic medicines. The company is also planning to launch a number of novel nutritional products to increase its range.

"Our focus area in futures will be marketing our ayurveda products in the domestic and international markets, " said Arvind Shah, Managing Director and CEO, Arvind Remedies.

The company has already developed speciality ayurvedic products - 'Pankare', which is the holistic drug for diabetes